Decreased Brain GABAA-Benzodiazepine Receptor Binding in Panic Disorder
Author(s) -
Andrea L. Malizia,
Vincent J. Cunningham,
Caroline Bell,
Peter F. Liddle,
Terry Jones,
David J. Nutt
Publication year - 1998
Publication title -
archives of general psychiatry
Language(s) - English
Resource type - Journals
eISSN - 1538-3636
pISSN - 0003-990X
DOI - 10.1001/archpsyc.55.8.715
Subject(s) - benzodiazepine , panic disorder , flumazenil , gabaa receptor , psychology , panic , radioligand , orbitofrontal cortex , psychosis , medicine , psychiatry , neuroscience , anxiety , endocrinology , receptor , prefrontal cortex , cognition
Positron emission tomography (PET) allows the measurement of benzodiazepine-gamma-aminobutyric acidA (GABA(A)) receptor kinetics. We employed flumazenil radiolabeled with carbon 11, a radioligand that labels the benzodiazepine site on the GABA(A) receptor, and fully quantitative, high-sensitivity PET to test the hypothesis that central benzodiazepine site binding is decreased in medication-free patients with panic disorder.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom